Searched for
JUBILANT PHARMOVA SHARES
Jubilant Pharmova block deal: Quant Mutual Fund offloads Rs 190 crore stake amid Rs 800 crore fundraising plan; Abakkus buys 11 lakh sharesQuant Mutual Fund sold 20.81 lakh shares of Jubilant Pharmova worth Rs 190.47 crore in bulk deals, while Abakkus Four2Eight Opportunities F...- Sunil Singhania-backed Abakkus Flexi Cap Fund increases stake in Dixon Technologies, OFSS, 30 others in AugustSunil Singhania-backed Abakkus Flexi Cap Fund increased its holdings in 32 stocks during August, including Dixon Technologies, OFSS, NTPC, ...
- Stocks in news: Tata Group stocks, HDFC Bank, Coforge, HFCL, Sun Pharma and Varun BeveragesOn September 11, Indian stock markets experienced a remarkable bounce back after an initial dip at opening. Key index heavyweights attracte...
- Stocks in news: Reliance Industries, Bank of Baroda, Power Grid, NATCO Pharma and JSW InfraIndian equity markets closed largely unchanged on Friday, August 21, after a volatile trading session. Several companies, including Relianc...
- Jubilant Pharmova shares decline 6% after Q1 profits falls 45% YoYJubilant Pharmova shares fell after Q1 profit plunged 45% YoY to Rs 56 crore, despite revenue rising 17% to Rs 2,229 crore. The profit decl...
- Jubilant Group promoters to offload stakes in listed companies via block deals: ReportJubilant Group stake sale: The Bhartia family plans to offload stakes in Jubilant FoodWorks, Pharmova, and Ingrevia via block deals. The mo...
- Jubilant promoters eye Rs 2,000 crore via stake sales for Hindustan Coca-Cola Beverages dealJubilant Bhartia Group's promoters are selling minority stakes in listed companies to raise ₹2,000 crore for partially funding the acquisit...
- Stocks in news: HDFC Bank, Vodafone Idea, Dr Reddy's, RIL, IndiGoStocks in news: Domestic markets continued their rebound, gaining nearly half a percent on Tuesday, driven by a recovery in global indices....
- Stocks in news: Bajaj Finance, Kronox Lab, IDBI Bank, Dr Reddy's, Godawari Power, Jubilant PharmovaDomestic markets navigated a volatile week, ending near all-time highs. Bajaj Finance filed for a Rs 7,000 crore IPO, Kronox Lab to debut w...
- Jubilant Pharmova shares jump over 6% on receiving USFDA approval for Technetium Sulfur Colloid InjectionFor this approval, Jubilant is eligible for 180 days of exclusivity through the ‘Competitive Generic Therapy’ designation from the US FDA.
- Jubilant Pharmova shares tumble over 11% as Q4 net loss widens sequentially to Rs 98 croreJubilant Pharmova's quarterly net loss widened to INR 98 crore in the March quarter of FY23 from a loss of INR 15.67 crore in the previous ...
- Buy Jubilant Pharmova, target price Rs 475: Anand RathiJubilant Pharmova, incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 6501.86 Crore) operating in Pharmaceutica...
- Buy Jubilant Pharmova, target price Rs 417: ICICI SecuritiesJubilant Pharmova Ltd., incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 5304.06 Crore) operating in Pharmace...
- Market movers: The curious case of buying and selling in BSE sharesJubilant Pharmova announced that one of its subsidiaries received Abbreviated New Drug Application (ANDA) final approval for Doxepin Hydroc...
- Jubilant Pharmova Q2 net dips 3% to Rs 143 croreConsolidated total revenue from operations stood at Rs 1,657.45 crore in the second quarter as against Rs 1,591.35 crore in the year-ago pe...
- Jubilant Pharmova Q1 results: Co posts net profit of Rs 160 croreRevenue from continuing operations stood at Rs 1,634.65 crore in the quarter under review. It was Rs 1,156.07 crore in the same period a ye...
- USFDA issues import alert on Jubilant Pharmova's Roorkee plantThe US Food and Drug Administration (USFDA) has taken the action after conducting an inspection of the formulations plant in March this yea...
- Buy Jubilant Pharmova, target price Rs 960: Motilal OswalJubilant Pharmova Ltd., incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 11743.00 Crore) operating in Pharmac...
- Jubilant Pharmova posts Rs 214 cr profit in Q4Sales stood at Rs 1,552 crore for the fourth quarter while the same was at Rs 1,497 crore in the same period of FY20.
- Jubilant Pharmova surges as company develops Remdesivir oral formHospitals and pharmacists in major cities have reported acute shortage of the drug due to supply constraints and alleged hoarding.
Load More
